|
浅议吉非替尼治疗老年晚期非小细胞肺癌的临床研究 |
| |
R, Bianco R,et al. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839(Iressa),a selective epidermal growth factor receptor tyrosine kinase inhibitor[J] .Clin Cancer Res,2001,7(5):14591465.
[3] Ryan PD, Chabner BA. On receptor inhibitors and chemoeherapy[J]. Clin Cancer Res,2000,6(12):46074609.
[4] Fukuoka M,Yano S, Giaccone G, et al. Multiinstitutional randomized phase Ⅱ trial of gefitinib for previously treated patients with advanced nonsmallcell lung cancer[J]. Clin Oncol,2003,21(12):22372246.
[5] Kris MG, Natale RB, Herbst RS,et al .Efficacy of gefitinib,an inhibitor of the epidermal growth factor receptor tyrosine kinase,in symptomatic patients with nonsmall cell lung cancer: a randomized trial[J]. JAMA,2003,290(16):21492158.
[6] Tamura K, Fukuoka M. Gefitinib in nonsmall cell lung cancer[J]. Expert Opin Pharmacother,2005,6(6):985993.
[7] Quoix E, Breton JL,Ducolone A, et al. First line chemotherapy with gemcitabine in advanced nonsmall cell lung cancer elderly patients :a randomized phase Ⅱ study of 3week versus 4week schedule[J]. Lung Cancer, 2005, 47(3):405412.
[8] Hainsworth JD,Burris HA, litchy S, et al. Weekly&上一页 [1] [2] [3] [4] [5] 下一页
上一个医学论文： 对老年恶性肿瘤患者合并医院内真菌感染调查
下一个医学论文： 浅议老年原发性高血压患者晨峰现象与靶器官损害
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文